The burden of hepatic diseases is substantial, demanding advanced therapeutic options. Regenerative therapies represent a especially exciting avenue, offering the chance to regenerate damaged hepatic tissue and improve clinical outcomes. Currently, research focuses on several methods, including the delivery of induced pluripotent cellular entities